1. Natural Products
  2. Plants Disease Research Fields Others
  3. Compositae Infection Inflammation/Immunology Umbelliferae
  4. Decachaeta ovatifolia (DC.) R.M.King & H.Rob.
  5. (+)-(3R,8S)-Falcarindiol

(+)-(3R,8S)-Falcarindiol  (Synonyms: (3R,8S)-Falcarindiol; 3(R),8(S),9(Z)-Falcarindiol)

Cat. No.: HY-N1976 Purity: 98.53%
Handling Instructions Technical Support

(+)-(3R,8S)-Falcarindiol ((3R,8S)-Falcarindiol; 3 (R),8 (S),9 (Z)-Falcarindiol) is an orally active polyacetylene anti-mycobacterial agent. (+)-(3R,8S)-Falcarindiol exhibits antibacterial activity against Gram-positive bacteria, Gram-negative bacteria and mycobacteria. Co-administration of (+)-(3R,8S)-Falcarindiol with (3R)-falcarinol alters the composition of gut microbiota, reduces colonic tumor lesions and slows down polyp growth. (+)-(3R,8S)-Falcarindiol can be used in research related to tuberculosis and colorectal cancer.

For research use only. We do not sell to patients.

(+)-(3R,8S)-Falcarindiol

(+)-(3R,8S)-Falcarindiol Chemical Structure

CAS No. : 225110-25-8

Size Price Stock Quantity
Liquid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Liquid
1 mg In-stock
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of (+)-(3R,8S)-Falcarindiol:

Top Publications Citing Use of Products

1 Publications Citing Use of MCE (+)-(3R,8S)-Falcarindiol

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

(+)-(3R,8S)-Falcarindiol ((3R,8S)-Falcarindiol; 3 (R),8 (S),9 (Z)-Falcarindiol) is an orally active polyacetylene anti-mycobacterial agent. (+)-(3R,8S)-Falcarindiol exhibits antibacterial activity against Gram-positive bacteria, Gram-negative bacteria and mycobacteria. Co-administration of (+)-(3R,8S)-Falcarindiol with (3R)-falcarinol alters the composition of gut microbiota, reduces colonic tumor lesions and slows down polyp growth. (+)-(3R,8S)-Falcarindiol can be used in research related to tuberculosis and colorectal cancer[1][2].

IC50 & Target

IC50: 6 μM (Mycobacterium tuberculosis H37Ra)[1]

Cellular Effect
Cell Line Type Value Description References
B16 IC50
2.9 μg/mL
Compound: 8
Inhibition of alpha-MSH-stimulated melanogenesis in mouse B16 cells assessed as melanin release after 72 hrs
Inhibition of alpha-MSH-stimulated melanogenesis in mouse B16 cells assessed as melanin release after 72 hrs
[PMID: 22450129]
CHO IC50
117.5 μM
Compound: 12
Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells by liquid scintillation counting
Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells by liquid scintillation counting
[PMID: 16643021]
HEK293 EC50
3.2 μM
Compound: Ref 6, Cpd 2
Activation of human PPARgamma expressed in HEK293 cells incubated for 18 hrs by luciferase reporter assay relative to control
Activation of human PPARgamma expressed in HEK293 cells incubated for 18 hrs by luciferase reporter assay relative to control
[PMID: 32129622]
HL-60 IC50
8.9 μM
Compound: 5
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
[PMID: 15387667]
HT-1080 IC50
13 μM
Compound: 5
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
[PMID: 15387667]
Hepatocyte IC50
> 100 μM
Compound: 21
Inhibitory activity against D-GalN-induced cytotoxicity in rat hepatocytes
Inhibitory activity against D-GalN-induced cytotoxicity in rat hepatocytes
[PMID: 9873511]
LoVo IC50
4.3 μM
Compound: 5
Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
[PMID: 15387667]
LoVo IC50
> 40 μM
Compound: 5
Cytotoxicity against human doxorubicin-resistant LoVo cells after 72 hrs by MTT assay
Cytotoxicity against human doxorubicin-resistant LoVo cells after 72 hrs by MTT assay
[PMID: 15387667]
In Vitro

(+)-(3R,8S)-Falcarindiol (0.20-400 µg/mL; 96 h) potently inhibits the growth of Mycobacterium tuberculosis H37Ra, with an IC50 of 6 μM and a MIC of 24 μM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Co-administration of (+)-(3R,8S)-Falcarindiol (7 µg/g; oral; continuous administration via diet; for 10 weeks) with (3R)-falcarinol significantly alters the composition of low-abundance members in the intestinal microbiota of rats and reduces colonic tumor lesions[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: F344 (male, 5 weeks old at arrival, injected with azoxymethane at 8 weeks of age)[2]
Dosage: 7 µg/g feed (in combination with 7 µg/g feed of (3R)-falcarinol)
Administration: p.o.; continuous via diet; from 2 weeks before AOM injection until euthanasia
Result: Significantly altered the composition of the less abundant members in the rat intestinal microbiota, but there was no systematic difference in the relative abundance of the dominant bacteria.
Reduced colon tumor lesions.
Molecular Weight

260.37

Formula

C17H24O2

CAS No.
Appearance

Liquid (Density: 1.000 g/cm3)

Color

Colorless to light yellow

SMILES

C=C[C@@H](O)C#CC#C[C@@H](O)/C=C\CCCCCCC

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Pure form -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 150 mg/mL (576.10 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.8407 mL 19.2034 mL 38.4069 mL
5 mM 0.7681 mL 3.8407 mL 7.6814 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (9.60 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (9.60 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.8407 mL 19.2034 mL 38.4069 mL 96.0172 mL
5 mM 0.7681 mL 3.8407 mL 7.6814 mL 19.2034 mL
10 mM 0.3841 mL 1.9203 mL 3.8407 mL 9.6017 mL
15 mM 0.2560 mL 1.2802 mL 2.5605 mL 6.4011 mL
20 mM 0.1920 mL 0.9602 mL 1.9203 mL 4.8009 mL
25 mM 0.1536 mL 0.7681 mL 1.5363 mL 3.8407 mL
30 mM 0.1280 mL 0.6401 mL 1.2802 mL 3.2006 mL
40 mM 0.0960 mL 0.4801 mL 0.9602 mL 2.4004 mL
50 mM 0.0768 mL 0.3841 mL 0.7681 mL 1.9203 mL
60 mM 0.0640 mL 0.3201 mL 0.6401 mL 1.6003 mL
80 mM 0.0480 mL 0.2400 mL 0.4801 mL 1.2002 mL
100 mM 0.0384 mL 0.1920 mL 0.3841 mL 0.9602 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
(+)-(3R,8S)-Falcarindiol
Cat. No.:
HY-N1976
Quantity:
MCE Japan Authorized Agent: